EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on the impact of curcumin on immune responses in breast cancer

Xiao Han, Renzhe Tang, Peng Wang, Li Liu

Open Life Sciences · 08.09.2025 · 20 (1)

DOI: 10.1515/biol-2025-1089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Open Life Sciences, online erschienen am 08.09.2025. Verfasst von Xiao Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150000, Heilongjiang, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Latin scientific name of turmeric is Curcuma longa L., and it belongs to the Zingiberaceae plant family. Curcumin is a yellow compound extracted from the rhizomes of turmeric, known for its various biological activities, including antioxidant, anti-inflammatory, and anticancer properties. This study presents a comprehensive review of the relationship between curcumin and the immune response in breast cancer (BC). Specific therapeutic approaches of curcumin for BC treatment are summarized. The anti-tumor activity of curcumin has garnered significant attention, with unique immunomodulatory effects on inhibiting cancer cell proliferation, inducing autophagy, affecting the cell cycle, and regulating cell apoptosis. Curcumin enhances immune cell-mediated actions against cancer cells through modulation of immune response pathways, alteration of the tumor microenvironment, and influencing immune cell function. Curcumin, via multiple pathways such as anti-inflammatory, antioxidant, apoptosis-inducing, and immunomodulatory effects, holds important clinical value in BC therapy.

Schlagwörter

Stichwörter der Autor:innen

breast cancercell apoptosiscurcuminimmune responsetherapeutic approaches

Autor:innen und Institutionen

  • Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150000, Heilongjiang, China.
  • The First Department of Cardiovascular, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150000, Heilongjiang, China.

Zitieren

APA

Han, X., Tang, R., Wang, P., & Liu, L. (2025). Research progress on the impact of curcumin on immune responses in breast cancer. Open Life Sciences, 20(1). https://doi.org/10.1515/biol-2025-1089

Vancouver

Han X, Tang R, Wang P, Liu L. Research progress on the impact of curcumin on immune responses in breast cancer. Open Life Sciences. 2025;20(1). doi:10.1515/biol-2025-1089

BibTeX
@article{Han2025,
  author = {Han, Xiao and Tang, Renzhe and Wang, Peng and Liu, Li},
  title = {Research progress on the impact of curcumin on immune responses in breast cancer},
  journal = {Open Life Sciences},
  year = {2025},
  volume = {20},
  number = {1},
  doi = {10.1515/biol-2025-1089}
}
Kostenlos starten →